SAN FRANCISCO - s4story -- QView Medical, the only company with FDA-approved artificial intelligence for breast ultrasound cancer detection, today announced a strategic partnership with Eve Wellness, the first company to offer direct-to-consumer breast cancer screening.

"We see Eve Wellness as the next frontier in early detection, where AI, ultrasound, and accessibility meet to give women with dense breast tissue confidence and clarity that mammography alone can't provide," said Bob Wang, CEO and founder of QView Medical.

QView's AI platform integrates with GE's Automated Breast Ultrasound (ABUS) system and is deployed in over 100 locations nationwide, including hospitals in Chicago, Atlanta, Salt Lake City, and Los Angeles. Clinical studies show the technology improves cancer detection, particularly in women with dense breast tissue, which can hide tumors in mammography.

"The important part of screening at Eve Wellness is the AI software that comes with it. The AI technology has gotten progressively better and better. It's been about three years since I have found a breast cancer that it wasn't able to pick up," said Dr. Ian Grady, Medical Director at Eve Wellness, on KRON4 TV

More on S For Story

• PlaceBased Media Expands Point-of-Care Advertising Inventory Across U.S. Clinic Network
• Inklet Press Announces Release Of The Third Book In The Children's Chapter Book Joylight Series
• Flexible Plan Investments launches FlexDirex, a first-to-market suite of single-stock ETF strategies in the U.S
• "Reality Behind the Fantasy" by Caroline Munro is now published
• Revenue Optics Ignites AI Revolution in Industrial Distribution

Eve Wellness has spent more than three years pioneering a patient-centric model that brings advanced breast cancer screening directly to women. By combining QView's FDA-approved AI with GE's 3D whole-breast ultrasound, Eve captures the entire breast, reducing the risk of missed cancers. This approach, which is then analyzed by one of the region's leading Breast Cancer physicians, offers highly effective detection in a more comfortable and convenient environment.

This model is particularly impactful for:

• Younger women under 40 who may not qualify for traditional mammography.
  
  
• Women with dense breast tissue, where mammography is known to be limited.
  
  
• Women seeking a non-invasive, more comfortable screening experience without hospital visits or physician referrals.

"Early detection saves lives, but we know mammography alone isn't enough, especially for younger women and those with dense breast tissue," said Brendan Foley, co-founder of Eve Wellness. "By combining FDA-cleared AI with 3D whole-breast ultrasound, we provide a more complete and highly effective screening experience that gives women confidence and control over their breast health."

More on S For Story

• Arnica Unveils "Arnie AI" to Secure the Future of AI-Driven Software Development
• Axiros North America Announces New CEO: Gabriel Davidov
• CCHR Exposes Harms Behind Today's Mental Health Awareness Campaigns
• Samantha Jones Releases New Book - Changing the Algorithm of Humanity
• Now Is the Right Time: Kaltra Highlights Its Proven Replacement Microchannel Coils

QView Medical and Eve Wellness are delivering a new standard in breast screening, one that is highly effective, accessible, and centered on women's needs.

About QView Medical, Inc.
QView Medical is a Silicon Valley, venture-backed AI company that has developed FDA-approved cancer detection AI algorithms, improving early detection and diagnostic accuracy. More information: www.qviewmedical.com

About Eve Wellness
Founded in San Francisco in 2022, Eve Wellness is the first direct-to-consumer breast screening service. Using advanced 3D ultrasound and AI technology, Eve provides women a fast, comfortable, and affordable way to screen. www.myevewellness.com